Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bone health in aging women with HIV
2017-002855-27Phase 4Completed
- Sponsor
- University Health Network
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of tenofovir disoproxil fumarate in human immunodeficiency virus infection (HIV) and Human immunodeficiency virus infection type 1 (2 arms), sponsored by University Health Network. Primary endpoint: Primary endpoint: Percent change from baseline in BMD between immediate vs delayed group. Started Jun 2021; status: completed.
02
Drugs
tenofovir disoproxil fumarate
03
Conditions
human immunodeficiency virus infection (HIV)Human immunodeficiency virus infection type 1
Beyond the preview
Go deeper on 2017-002855-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-002855-27.